NO20005480D0 - Carbapenemderivater, anvendelse derav samt mellomprodukt - Google Patents

Carbapenemderivater, anvendelse derav samt mellomprodukt

Info

Publication number
NO20005480D0
NO20005480D0 NO20005480A NO20005480A NO20005480D0 NO 20005480 D0 NO20005480 D0 NO 20005480D0 NO 20005480 A NO20005480 A NO 20005480A NO 20005480 A NO20005480 A NO 20005480A NO 20005480 D0 NO20005480 D0 NO 20005480D0
Authority
NO
Norway
Prior art keywords
intermediates
carbapenem derivatives
carbapenem
derivatives
Prior art date
Application number
NO20005480A
Other languages
English (en)
Other versions
NO20005480L (no
Inventor
Hiroshi Matsui
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10122499A external-priority patent/JP2000344772A/ja
Priority claimed from JP10203730A external-priority patent/JP2000344773A/ja
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of NO20005480D0 publication Critical patent/NO20005480D0/no
Publication of NO20005480L publication Critical patent/NO20005480L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005480A 1998-05-01 2000-10-31 Carbapenemderivater, anvendelse derav samt mellomprodukt NO20005480L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10122499A JP2000344772A (ja) 1998-05-01 1998-05-01 カルバペネム誘導体、その用途およびその中間体化合物
JP10203730A JP2000344773A (ja) 1998-07-17 1998-07-17 カルバペネム誘導体、およびその用途並びにその中間体化合物
PCT/JP1999/002301 WO1999057121A1 (fr) 1998-05-01 1999-04-28 Derives de carbapenem, son utilisation et composes intermediaires a base de carbapenem

Publications (2)

Publication Number Publication Date
NO20005480D0 true NO20005480D0 (no) 2000-10-31
NO20005480L NO20005480L (no) 2000-12-20

Family

ID=26459604

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005480A NO20005480L (no) 1998-05-01 2000-10-31 Carbapenemderivater, anvendelse derav samt mellomprodukt

Country Status (24)

Country Link
US (1) US6410525B1 (no)
EP (1) EP1078927B1 (no)
KR (1) KR100589030B1 (no)
CN (1) CN1163494C (no)
AR (1) AR018335A1 (no)
AT (1) ATE337321T1 (no)
AU (1) AU760386B2 (no)
BG (1) BG105004A (no)
BR (1) BR9910098A (no)
CA (1) CA2330641A1 (no)
CO (1) CO5011051A1 (no)
CZ (1) CZ292623B6 (no)
DE (1) DE69932927D1 (no)
HU (1) HUP0101735A3 (no)
ID (1) ID27081A (no)
NO (1) NO20005480L (no)
NZ (1) NZ508493A (no)
PL (1) PL343728A1 (no)
RU (1) RU2222540C2 (no)
SK (1) SK16382000A3 (no)
TR (1) TR200003199T2 (no)
TW (1) TW528750B (no)
WO (1) WO1999057121A1 (no)
YU (1) YU66700A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4068452B2 (ja) * 2000-07-19 2008-03-26 エフ．ホフマン−ラ ロシュ アーゲー エンドセリン変換酵素阻害剤としてのピロリジン誘導体
KR20040000466A (ko) * 2001-05-21 2004-01-03 교토 야쿠힝 고교 가부시키가이샤 카르바페넴 화합물
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
JP4377231B2 (ja) 2001-11-05 2009-12-02 大日本住友製薬株式会社 新規なカルバペネム化合物
WO2004089954A1 (ja) 2003-04-08 2004-10-21 Sumitomo Pharmaceuticals Co., Ltd. 新規なカルバペネム化合物
EP1785426A4 (en) * 2004-09-03 2008-02-20 Dainippon Sumitomo Pharma Co NEW CARBAPENEM DERIVATIVE
WO2006103999A1 (ja) * 2005-03-25 2006-10-05 Dainippon Sumitomo Pharma Co., Ltd. 新規なカルバペネム化合物
CN101291916A (zh) * 2005-08-31 2008-10-22 惠氏公司 甘氨酰环素的9-氨基羰基取代衍生物
CN101376656A (zh) * 2007-08-30 2009-03-04 山东轩竹医药科技有限公司 培南衍生物
CA2906689A1 (en) 2013-03-15 2014-09-18 Kala Pharmaceuticals, Inc. Meropenem derivatives and uses thereof
US11180500B2 (en) * 2018-10-01 2021-11-23 Arixa Pharmaceuticals, Inc. Derivatives of relebactam and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60233076A (ja) 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
FI81576C (fi) 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
IE60588B1 (en) 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
US5242914A (en) 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
DK175029B1 (da) 1988-04-01 2004-05-03 Sankyo Co 2-(heterocyclylthio)carbapenemderivater, farmaceutiske midler indeholdende dem, fremgangsmåde til fremstilling deraf samt deres anvendelse som antibiotika
AU644008B2 (en) 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
US5712267A (en) 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
US5360798A (en) 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
ES2181927T3 (es) 1995-12-21 2003-03-01 Sankyo Co Derivados de 1-metilcarbapenem.

Also Published As

Publication number Publication date
WO1999057121A1 (fr) 1999-11-11
CO5011051A1 (es) 2001-02-28
EP1078927A1 (en) 2001-02-28
NO20005480L (no) 2000-12-20
ATE337321T1 (de) 2006-09-15
CZ292623B6 (cs) 2003-11-12
KR20010043196A (ko) 2001-05-25
AR018335A1 (es) 2001-11-14
YU66700A (sh) 2003-01-31
HUP0101735A3 (en) 2002-02-28
BR9910098A (pt) 2000-12-26
CN1163494C (zh) 2004-08-25
KR100589030B1 (ko) 2006-06-13
PL343728A1 (en) 2001-09-10
EP1078927B1 (en) 2006-08-23
US6410525B1 (en) 2002-06-25
SK16382000A3 (sk) 2001-05-10
TW528750B (en) 2003-04-21
NZ508493A (en) 2002-06-28
AU760386B2 (en) 2003-05-15
BG105004A (en) 2001-08-31
AU3627299A (en) 1999-11-23
EP1078927A4 (en) 2003-01-08
CA2330641A1 (en) 1999-11-11
HUP0101735A2 (hu) 2001-12-28
DE69932927D1 (de) 2006-10-05
CZ20003954A3 (cs) 2001-04-11
RU2222540C2 (ru) 2004-01-27
ID27081A (id) 2001-02-22
TR200003199T2 (tr) 2001-03-21
CN1307578A (zh) 2001-08-08

Similar Documents

Publication Publication Date Title
DE69720051D1 (de) Harnstoffderivate
ATE256123T1 (de) Pyrimidonderivate
PT1104239E (pt) Herbicidas com aminofenilsulfonilureias acilatadas
IS5699A (is) Ný notkun
DE69720531D1 (de) Laserinduzierte vergütete oberflächen
NO20010193D0 (no) Tiobenzimidazol-derivater
DK0930302T3 (da) Benzosulfonderivater
IS4800A (is) Nýjar 19-nor-pregnene afleiður
ATE259810T1 (de) Phenyl-xanthinderivate
NO20010514L (no) Aminometylkarboksylsyre-derivater
TR199800117A3 (tr) Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi.
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
NO20024806D0 (no) Apomorfinderivater samt anvendelse derav
BR9507666A (pt) Novos derivados de pirimidina
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
NO20005480D0 (no) Carbapenemderivater, anvendelse derav samt mellomprodukt
DE19980175D2 (de) Farbdose
DK0726265T3 (da) 10-Aminoaliphatyl-dibenz[b,f]oxepiner med antineurodegenerativ virkning
NO20011512D0 (no) 2-Fenylpyran-4-on derivater
ATE233253T1 (de) Chromanderivate
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
DK1060183T3 (da) 5-deoxycytidinderivater
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate
FI961877A0 (fi) Styrbar axelkonstruktion foer nyttofordon
NO971917L (no) Hyllekj°ler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application